Director's Dealing • Sep 25, 2025
Director's Dealing
Open in ViewerOpens in native device viewer
| Transaction notification as referred to in Article 19(1) of the MAR Regulation | ||||
|---|---|---|---|---|
| 1 | Details of the person discharging managerial responsibilities/closely related to him/her | |||
| a) | Name | Charles Kunsch | ||
| 2 | Reason for notification | |||
| a) | Position/status | Member of the Supervisory Board | ||
| b) | Initial notification/change |
Initial notification | ||
| 3 | Issuer data | |||
| a) | Name | Captor Therapeutics S.A. | ||
| b) | LEI | 259400JHH1S2I2S4O735 | ||
| 4 | Transaction details: this column should be completed for (i) each type of instrument; (ii) each type of transaction; (iii) date; and (iv) each place where the transactions were carried out |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary bearer shares ISIN: PLCPTRT00014 |
||
| b) | Type of transaction | Subscription | ||
| c) | Price and volume | Price | Volume | |
| 105,2 PLN |
1052 | |||
| d) | Summary information |
| - Total volume |
1052 | |
|---|---|---|
| - Price |
105,2 PLN |
|
| e) | Transaction date | 2025-09-24 |
| f) | Place of transaction | Outside a trading market |
_______________________
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.